Stopping Semaglutide or Tirzepatide: The Right Way For patients considering discontinuing GLP-1 therapy, providers can develop a structured transition plan
Tesofensine also caused changes in the expression of dopamine receptors and the dopamine transporter in the brain
When used as monotherapy, Rybelsus carries a low risk of hypoglycaemia compared to sulphonylureas or insulin
I have had acid reflux, burping, vomiting, constipation, headache, and dizziness
This weight loss is not only substantial but also sustainable, with many users maintaining their reduced body weight over extended periods
In the UK, the reporting of suspected side effects and drug interactions is a vital component of ongoing drug safety monitoring